scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in scPharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +4 vs. Q4 2021
- Shares held
- 15.9M
- −53.1K (−0.3%) vs. Q4 2021
- Total value
- $90.1M
- +$10.1M (+12.7%) vs. Q4 2021
- New holders
- 6
- 8 more added
- Sold out
- 2
- 14 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 61 | $0 | 0.00% | +1+1.7% | Added |
| Royal Bank of Canada | 56 | $0 | 0.00% | −17−23.3% | Reduced |
| BNP Paribas Arbitrage, SA | 106 | $602 | 0.00% | −277−72.3% | Reduced |
| Tower Research Capital LLC (TRC) | 100 | $1.00K | 0.00% | +100 | New |
| Group One Trading, L.P. | 654 | $4.00K | 0.00% | +654 | New |
| FMR LLC | 889 | $5.00K | 0.00% | +889 | New |
| UBS Group AG | 1,000 | $6.00K | 0.00% | −1,253−55.6% | Reduced |
| Bank of America Corp | 1,039 | $6.00K | 0.00% | −133−11.3% | Reduced |
| Advisor Group Holdings, Inc. | 3,637 | $21.0K | 0.00% | −270−6.9% | Reduced |
| Envestnet Asset Management Inc | 10,228 | $58.0K | 0.00% | −2,654−20.6% | Reduced |
| Sandy Cove Advisors, LLC | 10,592 | $60.0K | 0.05% | 00.0% | Unchanged |
| IPG Investment Advisors LLC | 14,300 | $81.0K | 0.02% | 00.0% | Unchanged |
| Thomasville National Bank | 15,000 | $85.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 15,100 | $86.0K | 0.00% | +1,100+7.9% | Added |
| Simplex Trading, LLC | 23,156 | $131.0K | 0.00% | +22,617+4,196.1% | Added |
| Millennium Management LLC | 24,771 | $141.0K | 0.00% | −8,567−25.7% | Reduced |
| Citadel Advisors LLC | 31,494 | $179.0K | 0.00% | +31,494 | New |
| Bank of New York Mellon Corp | 34,603 | $196.0K | 0.00% | −40−0.1% | Reduced |
| Zacks Investment Management | 36,989 | $210.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 40,689 | $231.0K | 0.00% | +40,689 | New |
| Northern Trust Corp | 48,908 | $278.0K | 0.00% | −802−1.6% | Reduced |
| BlackRock Inc. | 57,883 | $329.0K | 0.00% | −1,602−2.7% | Reduced |
| J. Goldman & Co LP | 67,500 | $383.0K | 0.03% | −302,591−81.8% | Reduced |
| Geode Capital Management, LLC | 69,252 | $393.0K | 0.00% | −1,957−2.7% | Reduced |
| Boothbay Fund Management, LLC | 86,635 | $492.0K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 86,585 | $492.0K | 0.00% | +11,750+15.7% | Added |
| Dimensional Fund Advisors LP | 103,534 | $588.0K | 0.00% | +6,787+7.0% | Added |
| Bridgeway Capital Management, LLC | 132,200 | $751.0K | 0.01% | 00.0% | Unchanged |
| Belvedere Trading LLC | 160,882 | $822.0K | 0.58% | +160,882 | New |
| Renaissance Technologies LLC | 186,086 | $1.06M | 0.00% | −2,900−1.5% | Reduced |
| Worth Venture Partners, LLC | 348,425 | $1.98M | 0.93% | +15,778+4.7% | Added |
| Vanguard Group Inc | 616,558 | $3.50M | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 970,098 | $5.51M | 1.68% | +68,736+7.6% | Added |
| AIGH Capital Management LLC | 1,396,724 | $7.93M | 2.88% | +23,600+1.7% | Added |
| Ra Capital Management, L.P. | 2,658,583 | $15.1M | 0.33% | −33,187−1.2% | Reduced |
| 5AM Venture Management, LLC | 3,831,474 | $21.8M | 4.75% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,797,148 | $27.2M | 0.44% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −81,891−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −14−100.0% | Sold out |